Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats

European Journal of Clinical Investigation

Volumn 29, Issue 6, 1999, Pages 529-535

  Szabo A ^a   Freesmeyer, M G ^c   Abendroth, K ^c   Stein, G ^c   Rosivall, L ^c   El Shakmak, A ^c   Ritz, E ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c NONE

Author keywords

Calcitriol; Parathyroid hormone; Parathyroid hormone resistance; Secondary hyperparathyroidism; Uraemia

Indexed keywords

CALCITRIOL; CALCIUM ION; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34];

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; KIDNEY FAILURE; MALE; MORPHOMETRICS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PARATHYROIDECTOMY; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RAT; UREMIA;

EID: 0033049751     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00499.x     Document Type: Article

References (29)

1. 1 Cohen Solal ME, Sehert JT., Boudailliez B, et al. Non aluminic adynamic bone disease in non dialyzed uremic patients: a new type of osteopathy due to overtreatment. Bone 1992; 13: 1-5.
2. 2 Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyruid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab, 1992; 75: 145-50.
3. 3 Sherrard DJ, Herz. G, Pei Y, et al. The spectrum of bone disease in end-stage renal failure-an evolving disorder. Kidney Int, 1993; 43: 436-42.
4. 4 Jüppner M, Abou-Samra AB, Freeman M, et al, A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science, 1991; 254: 1024-6.
5. 5 Urena P, Serge GV, Drüeke TB. Parathyroid hormone receptor (Review). Nephrol Dial Transplant 1994; 9: 593-5.
6. 6 Urena P, Kubrusly M, Mannstadt M, Drüeke TB. The renal PTH/PTH rP receptor is down regulated in rats with chronic renal failure. Kidney Int, 1994; 45: 605-11.
7. 7 Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med, 1995; 333: 166-74.
8. 8 Suda T, Takahasi N, Martin TJ. Modulation of osteoclast differentiation. Endocrinol Rev, 1992; 13: 66-80.
9. 9 McSheehy PMJ Chambers TJ. Osteoblast-like cells in the presence ot parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology, 1986; 119: 1654-9.
10. 1 in the parathyroid glands of patients with renal failure. N Engl J Med, 1987; 316: 1573-7.
11. 3 receptors in experimental uremia, Kidney Int, 1987; 32: 350-3.
12. 9k in uremic rats. Eur J Clin Invest, 1991; 21: 521-6.
13. 13 Koyama H, Nishizawa Y, Inaba M, et al. Impaired homologous upregulation of vitamin D receptor in rats with chronic renal failure. Am J Physiol, 1994; 266: F706-12.
14. 14 Hsu CH, Patel SR. Altered vitamin D metabolism and receptor interaction with the target genes in renal failure: calcitriol receptor interaction with its gene in renal failure. Curr Opin Nephrol Hypertension, 1995; 4: 302-7.
15. 15 Toverud SU, Boass A, Garner SC, Endress DB. Circulating parathyroid hormone concentrations in normal and vitamin D deprived rat pups determined with an N-terminal specific radioimmunoassay. J Bone Miner Rea, 1986; 1: 145-55.
16. 16 Scharla S, Schmidt-Gayk H, Reichel H, Mayer E, A sensitive and simplified radioimmunoassay for 1,25-dihydroxyvitamin D3. Clin Chem Acta, 1984, 142: 325-38.
17. 17 Goldner J. A modification of the Masson trichrome technique for routine laboratory purposes. Am J Pathol, 1938; 14: 237-43.
18. 18 Gomori G. Microtechnical demonstration: a criticisms of its methods. Am J Pathol, 1936; 12: 655 -63.
19. 19 Schenk RK, Olah JA, Hermann W. Preparation of calcified tissue for light microscopy. In: Dockson GR, editor. Methods of calcified tissue preparation. Amsterdam: Elsevier; 1984. p. 1-56.
20. 20 Bartl R, Frisch B. Biopsy of bone in internal medicine In: Gresham A, editor, Current histopathology, Vol. 21. Dordrecht: Kluwer Academic Publisher; 1993. p.53-60.
21. 21 Parfitt AM, Drezner MK, Glorieux FM, et al. Bone histomorphometry standardisation of nomenclature, symbols and units. J Bone Miner Res, 1987; 2. 595-610.
22. 22 Massry SG, Coburn JW, Lee DBN, Jowsey J, Kleeman CR. Skeletal resistance to calcemic action of parathyroid hormone in renal failure; studies on 105 human subjects. Am Int Med, 1973; 78: 337-41.
23. 23 Massry SG, Stein R, Garty J, et al. Skeletal resistance to calcemic action of parathyroid hormone: role of 1,25(OH)2D3. Kidney Int, 1976; 9: 467-2.
24. 24 Klaus G, May T, Hügel U, et al. Parathyroid hormone prevents 1,25(OH)2D3 induced down-regulation of the vitamin D receptor in growth plate chondrocytes in vitro. Kidney Int, 1997; 2: 45-52,
25. 25 Kelly KJ, Bonventre JV. Osteogenic protein-1 protect the rat kidney from ischemi injury. J Am Soc Nephrol, 1997; 8: 1827.
26. 26 Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 1998; 93: 165-76.
27. 27 Hruska K. New concepts in renal osteodystrophy. Nephrol Dial Transplant 1998; 13: 2755-61.
28. 28 Martinez ME, Garcia-Ocana A, Sanches M, et al. C-Terminal hormone-related protein inhibits proliferation and differentiation of human osteoblast-like cells, J Bone Min Res, 1997, 12: 778-85.
29. 29 Valin A, Garcia-Ocana A, De Miguel F, Sarasa JL, Esbrit P. Antiproliferative effect of the C-terminal fragments of parathyroid hormone-related protein, PTHrP-(107-111) and (107-139), on osteoblastic osteosarcoma cells. J Cell Physiol, 1997; 170: 209-15.